CXCR5 and Autoimmunity: As such, BBR’s suppressive effect on CXCR5+ Tfh cell populations, while potentially beneficial for autoimmune pathologies, also raises concern that prolonged use could impact a patient’s ability to mount effective beneficial primary adaptive immune responses.